Clinical Trial Update: Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia [Phase 2]

View source ↗

Summary

Phase 2 trial update on pioglitazone hydrochloride for preventing head and neck cancer in patients with oral leukoplakia; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Leukoplakia

Drugs mentioned

• Pioglitazone hydrochloride (Pioglitazone hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Head and Neck Cancer, Oral Leukoplakia | Phase 2 | Status: COMPLETED | Results posted: 2009-11-25